VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment The Trade TTD Stock Institutional Buying Advances 20260427 Impact BioMedical IBO CEO lays out novel drug pipeline priorities to drive longterm global market expansion